Cargando…
Expanding the clinical phenotype of IARS2-related mitochondrial disease
BACKGROUND: IARS2 encodes a mitochondrial isoleucyl-tRNA synthetase, a highly conserved nuclear-encoded enzyme required for the charging of tRNAs with their cognate amino acid for translation. Recently, pathogenic IARS2 variants have been identified in a number of patients presenting broad clinical...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233262/ https://www.ncbi.nlm.nih.gov/pubmed/30419932 http://dx.doi.org/10.1186/s12881-018-0709-3 |
_version_ | 1783370551676370944 |
---|---|
author | Vona, Barbara Maroofian, Reza Bellacchio, Emanuele Najafi, Maryam Thompson, Kyle Alahmad, Ahmad He, Langping Ahangari, Najmeh Rad, Abolfazl Shahrokhzadeh, Sima Bahena, Paulina Mittag, Falk Traub, Frank Movaffagh, Jebrail Amiri, Nafise Doosti, Mohammad Boostani, Reza Shirzadeh, Ebrahim Haaf, Thomas Diodato, Daria Schmidts, Miriam Taylor, Robert W. Karimiani, Ehsan Ghayoor |
author_facet | Vona, Barbara Maroofian, Reza Bellacchio, Emanuele Najafi, Maryam Thompson, Kyle Alahmad, Ahmad He, Langping Ahangari, Najmeh Rad, Abolfazl Shahrokhzadeh, Sima Bahena, Paulina Mittag, Falk Traub, Frank Movaffagh, Jebrail Amiri, Nafise Doosti, Mohammad Boostani, Reza Shirzadeh, Ebrahim Haaf, Thomas Diodato, Daria Schmidts, Miriam Taylor, Robert W. Karimiani, Ehsan Ghayoor |
author_sort | Vona, Barbara |
collection | PubMed |
description | BACKGROUND: IARS2 encodes a mitochondrial isoleucyl-tRNA synthetase, a highly conserved nuclear-encoded enzyme required for the charging of tRNAs with their cognate amino acid for translation. Recently, pathogenic IARS2 variants have been identified in a number of patients presenting broad clinical phenotypes with autosomal recessive inheritance. These phenotypes range from Leigh and West syndrome to a new syndrome abbreviated CAGSSS that is characterised by cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, as well as cataract with no additional anomalies. METHODS: Genomic DNA from Iranian probands from two families with consanguineous parental background and overlapping CAGSSS features were subjected to exome sequencing and bioinformatics analysis. RESULTS: Exome sequencing and data analysis revealed a novel homozygous missense variant (c.2625C > T, p.Pro909Ser, NM_018060.3) within a 14.3 Mb run of homozygosity in proband 1 and a novel homozygous missense variant (c.2282A > G, p.His761Arg) residing in an ~ 8 Mb region of homozygosity in a proband of the second family. Patient-derived fibroblasts from proband 1 showed normal respiratory chain enzyme activity, as well as unchanged oxidative phosphorylation protein subunits and IARS2 levels. Homology modelling of the known and novel amino acid residue substitutions in IARS2 provided insight into the possible consequence of these variants on function and structure of the protein. CONCLUSIONS: This study further expands the phenotypic spectrum of IARS2 pathogenic variants to include two patients (patients 2 and 3) with cataract and skeletal dysplasia and no other features of CAGSSS to the possible presentation of the defects in IARS2. Additionally, this study suggests that adult patients with CAGSSS may manifest central adrenal insufficiency and type II esophageal achalasia and proposes that a variable sensorineural hearing loss onset, proportionate short stature, polyneuropathy, and mild dysmorphic features are possible, as seen in patient 1. Our findings support that even though biallelic IARS2 pathogenic variants can result in a distinctive, clinically recognisable phenotype in humans, it can also show a wide range of clinical presentation from severe pediatric neurological disorders of Leigh and West syndrome to both non-syndromic cataract and cataract accompanied by skeletal dysplasia. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12881-018-0709-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6233262 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-62332622018-11-20 Expanding the clinical phenotype of IARS2-related mitochondrial disease Vona, Barbara Maroofian, Reza Bellacchio, Emanuele Najafi, Maryam Thompson, Kyle Alahmad, Ahmad He, Langping Ahangari, Najmeh Rad, Abolfazl Shahrokhzadeh, Sima Bahena, Paulina Mittag, Falk Traub, Frank Movaffagh, Jebrail Amiri, Nafise Doosti, Mohammad Boostani, Reza Shirzadeh, Ebrahim Haaf, Thomas Diodato, Daria Schmidts, Miriam Taylor, Robert W. Karimiani, Ehsan Ghayoor BMC Med Genet Research Article BACKGROUND: IARS2 encodes a mitochondrial isoleucyl-tRNA synthetase, a highly conserved nuclear-encoded enzyme required for the charging of tRNAs with their cognate amino acid for translation. Recently, pathogenic IARS2 variants have been identified in a number of patients presenting broad clinical phenotypes with autosomal recessive inheritance. These phenotypes range from Leigh and West syndrome to a new syndrome abbreviated CAGSSS that is characterised by cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, as well as cataract with no additional anomalies. METHODS: Genomic DNA from Iranian probands from two families with consanguineous parental background and overlapping CAGSSS features were subjected to exome sequencing and bioinformatics analysis. RESULTS: Exome sequencing and data analysis revealed a novel homozygous missense variant (c.2625C > T, p.Pro909Ser, NM_018060.3) within a 14.3 Mb run of homozygosity in proband 1 and a novel homozygous missense variant (c.2282A > G, p.His761Arg) residing in an ~ 8 Mb region of homozygosity in a proband of the second family. Patient-derived fibroblasts from proband 1 showed normal respiratory chain enzyme activity, as well as unchanged oxidative phosphorylation protein subunits and IARS2 levels. Homology modelling of the known and novel amino acid residue substitutions in IARS2 provided insight into the possible consequence of these variants on function and structure of the protein. CONCLUSIONS: This study further expands the phenotypic spectrum of IARS2 pathogenic variants to include two patients (patients 2 and 3) with cataract and skeletal dysplasia and no other features of CAGSSS to the possible presentation of the defects in IARS2. Additionally, this study suggests that adult patients with CAGSSS may manifest central adrenal insufficiency and type II esophageal achalasia and proposes that a variable sensorineural hearing loss onset, proportionate short stature, polyneuropathy, and mild dysmorphic features are possible, as seen in patient 1. Our findings support that even though biallelic IARS2 pathogenic variants can result in a distinctive, clinically recognisable phenotype in humans, it can also show a wide range of clinical presentation from severe pediatric neurological disorders of Leigh and West syndrome to both non-syndromic cataract and cataract accompanied by skeletal dysplasia. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12881-018-0709-3) contains supplementary material, which is available to authorized users. BioMed Central 2018-11-12 /pmc/articles/PMC6233262/ /pubmed/30419932 http://dx.doi.org/10.1186/s12881-018-0709-3 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Vona, Barbara Maroofian, Reza Bellacchio, Emanuele Najafi, Maryam Thompson, Kyle Alahmad, Ahmad He, Langping Ahangari, Najmeh Rad, Abolfazl Shahrokhzadeh, Sima Bahena, Paulina Mittag, Falk Traub, Frank Movaffagh, Jebrail Amiri, Nafise Doosti, Mohammad Boostani, Reza Shirzadeh, Ebrahim Haaf, Thomas Diodato, Daria Schmidts, Miriam Taylor, Robert W. Karimiani, Ehsan Ghayoor Expanding the clinical phenotype of IARS2-related mitochondrial disease |
title | Expanding the clinical phenotype of IARS2-related mitochondrial disease |
title_full | Expanding the clinical phenotype of IARS2-related mitochondrial disease |
title_fullStr | Expanding the clinical phenotype of IARS2-related mitochondrial disease |
title_full_unstemmed | Expanding the clinical phenotype of IARS2-related mitochondrial disease |
title_short | Expanding the clinical phenotype of IARS2-related mitochondrial disease |
title_sort | expanding the clinical phenotype of iars2-related mitochondrial disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233262/ https://www.ncbi.nlm.nih.gov/pubmed/30419932 http://dx.doi.org/10.1186/s12881-018-0709-3 |
work_keys_str_mv | AT vonabarbara expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease AT maroofianreza expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease AT bellacchioemanuele expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease AT najafimaryam expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease AT thompsonkyle expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease AT alahmadahmad expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease AT helangping expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease AT ahangarinajmeh expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease AT radabolfazl expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease AT shahrokhzadehsima expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease AT bahenapaulina expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease AT mittagfalk expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease AT traubfrank expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease AT movaffaghjebrail expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease AT amirinafise expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease AT doostimohammad expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease AT boostanireza expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease AT shirzadehebrahim expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease AT haafthomas expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease AT diodatodaria expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease AT schmidtsmiriam expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease AT taylorrobertw expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease AT karimianiehsanghayoor expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease |